The primary outcome was the change in body weight
It is not classified as a drug, food, or cosmetic and must not be misrepresented, misused, or mislabeled as such.
From August to September, there was nearly a 20% increase in the number of lawsuits in the multidistrict litigation (MDL)
Beyond glucose-lowering, tirzepatide achieved remarkable and sustained weight loss, with mean reductions exceeding 20% in non-diabetic adults with obesity after 72 weeks
Provided in sealed containers, this material is suitable for professional research environments that rely on standardized workflows and accurate record keeping
How Much Do GLP-1 Medications Cost